J
Judith Collins
Researcher at Oregon Health & Science University
Publications - 34
Citations - 2488
Judith Collins is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Ulcerative colitis & Golimumab. The author has an hindex of 12, co-authored 34 publications receiving 2268 citations. Previous affiliations of Judith Collins include Rutgers University & University of Surrey.
Papers
More filters
Journal ArticleDOI
Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
William J. Sandborn,Brian G. Feagan,Colleen Marano,Hongyan Zhang,Richard Strauss,Jewel Johanns,Omoniyi J. Adedokun,Cynthia Guzzo,Jean-Frederic Colombel,Jean-Frederic Colombel,Walter Reinisch,Peter R. Gibson,Judith Collins,Gunnar Järnerot,Toshifumi Hibi,Paul Rutgeerts +15 more
TL;DR: Treatment with subcutaneous golimumab induces clinical response, remission, and mucosal healing, and increases quality of life in larger percentages of patients with active UC than placebo.
Journal ArticleDOI
Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.
William J. Sandborn,Brian G. Feagan,Colleen Marano,Hongyan Zhang,Richard Strauss,Jewel Johanns,Omoniyi J. Adedokun,Cynthia Guzzo,Jean-Frederic Colombel,Jean-Frederic Colombel,Walter Reinisch,Peter R. Gibson,Judith Collins,Gunnar Järnerot,Paul Rutgeerts +14 more
TL;DR: Golimumab (50 mg or 100 mg) maintained clinical response through week 54 in patients who responded to induction therapy with golimumab and had moderate-to-severe active ulcerative colitis; patients who received 100 mg Golimumab had clinical remission and mucosal healing at weeks 30 and 54.
Journal ArticleDOI
Five-year colon surveillance after screening colonoscopy.
David A. Lieberman,David G. Weiss,William V. Harford,Dennis J. Ahnen,Dawn Provenzale,Stephen J. Sontag,Thomas G. Schnell,Gregorio Chejfec,Donald R. Campbell,Jayashri Kidao,John H. Bond,Douglas B. Nelson,George Triadafilopoulos,Francisco C. Ramirez,Judith Collins,Tiina K. Johnston,Kenneth R. McQuaid,Harinder S. Garewal,Richard E. Sampliner,Romeo Esquivel,Douglas J. Robertson +20 more
TL;DR: There is a strong association between results of baseline screening colonoscopy and rate of serious incident lesions during 5.5 years of surveillance and patients with 1 or 2 tubular adenomas less than 10 mm represent a low-risk group compared with other patients with colon neoplasia.
Journal ArticleDOI
Accuracy of Screening for Fecal Occult Blood on a Single Stool Sample Obtained by Digital Rectal Examination: A Comparison With Recommended Sampling Practice
TL;DR: The primary aim of the current study was to compare the sensitivity and specificity of digital F OBT and recommended 6-sample FOBT in asymptomatic patients who had both types of FOBt and underwent complete screening colonoscopy regardless of FABT results.
Journal ArticleDOI
Preliminary report on isolation of mycobacteria from patients with Crohn's disease.
Gary Gitnick,Judith Collins,Judith Collins,Judith Collins,Blaine Beaman,Blaine Beaman,Blaine Beaman,Dale Brooks,Dale Brooks,Dale Brooks,Marika Arthur,Marika Arthur,Marika Arthur,Tamotsu Imaeda,Tamotsu Imaeda,Tamotsu Imaeda,Mary Palieschesky,Mary Palieschesky,Mary Palieschesky +18 more
TL;DR: The isolation of four mycobacteria from 27 CD tissues and only one from 55 control tissues strengthens the findings of previous investigators and supports the hypothesis that myCobacteria may be etiologically associated with some cases of Crohn's disease.